Sem-P™
Therapeutic Segment:
Anti-Diabetic
Generic Name:
Semaglutide
Indication
Injection
- 2mg/1.5ml
- 4mg/3ml
Sem-P is indicated:
- As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.
- As monotherapy when metformin is considered inappropriate due to intolerance or contraindication.
- In addition to other medicinal products for the treatment of diabetes.